Correlation Between Dermata Therapeutics and Mesoblast
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Mesoblast, you can compare the effects of market volatilities on Dermata Therapeutics and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Mesoblast.
Diversification Opportunities for Dermata Therapeutics and Mesoblast
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dermata and Mesoblast is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Mesoblast go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Mesoblast
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Mesoblast. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 1.4 times less risky than Mesoblast. The stock trades about -0.22 of its potential returns per unit of risk. The Mesoblast is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 937.00 in Mesoblast on August 24, 2024 and sell it today you would earn a total of 81.00 from holding Mesoblast or generate 8.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. Mesoblast
Performance |
| Timeline |
| Dermata Therapeutics |
| Mesoblast |
Dermata Therapeutics and Mesoblast Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Mesoblast
The main advantage of trading using opposite Dermata Therapeutics and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
| Mesoblast vs. Aditxt Inc | Mesoblast vs. Lipocine | Mesoblast vs. Connect Biopharma Holdings | Mesoblast vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |